SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-09-15
DOI
10.1186/s12967-022-03629-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blocking connexin 43 and its promotion of ATP release from renal tubular epithelial cells ameliorates renal fibrosis
- (2022) Huzi Xu et al. Cell Death & Disease
- KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease
- (2021) Yutaro Mori et al. Cell Metabolism
- Peroxisomal-derived ether phospholipids link nucleotides to respirasome assembly
- (2021) Christopher F. Bennett et al. Nature Chemical Biology
- DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance
- (2021) Juan Zhang et al. iScience
- MHC class II in renal tubules plays an essential role in renal fibrosis
- (2021) Yunfeng Zhou et al. Cellular & Molecular Immunology
- Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin
- (2021) Shih-Jie Jhuo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Impaired Nicotinamide Adenine Dinucleotide Biosynthesis in the Kidney of Chronic Kidney Disease
- (2021) Xinhui Liu et al. Frontiers in Physiology
- Metabolic Changes and Oxidative Stress in Diabetic Kidney Disease
- (2021) Midori Sakashita et al. Antioxidants
- NAD+ Homeostasis in Diabetic Kidney Disease
- (2021) Jing Xu et al. Frontiers in Medicine
- Lysine 2-hydroxyisobutyrylation proteomics reveals protein modification alteration in the actin cytoskeleton pathway of oral squamous cell carcinoma
- (2021) Zeyu Zhang et al. Journal of Proteomics
- A low aromatic amino-acid diet improves renal function and prevent kidney fibrosis in mice with chronic kidney disease
- (2021) Christophe Barba et al. Scientific Reports
- Mitochondria in Diabetic Kidney Disease
- (2021) Amna Ayesha Ahmad et al. Cells
- Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus
- (2021) Chunyu Zhou et al. Frontiers in Medicine
- d-Amino acids and kidney diseases
- (2020) Tomonori Kimura et al. Clinical and Experimental Nephrology
- Serum hepcidin, the hepcidin/ferritin ratio and the risk of type 2 diabetes: a systematic review and meta-analysis
- (2020) Nahid Karamzad et al. CURRENT MEDICINAL CHEMISTRY
- Cell junction proteins: Crossing the glomerular filtration barrier in diabetic nephropathy
- (2020) Aziz Eftekhari et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
- (2020) Anton I. Korbut et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?
- (2020) Anne C. Hesp et al. KIDNEY INTERNATIONAL
- Sodium–glucose cotransporter 2 inhibition suppresses HIF-1α-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice
- (2020) Ting Cai et al. Cell Death & Disease
- Metabolic Dynamics and Prediction of Gestational Age and Time to Delivery in Pregnant Women
- (2020) Liang Liang et al. CELL
- SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition
- (2020) Issei Tomita et al. Cell Metabolism
- SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
- (2020) Martin R. Cowie et al. Nature Reviews Cardiology
- Conversion of extracellular ATP into adenosine: a master switch in renal health and disease
- (2020) Karen M. Dwyer et al. Nature Reviews Nephrology
- Proximal Tubule mTORC1 Is a Central Player in the Pathophysiology of Diabetic Nephropathy and Its Correction by SGLT2 Inhibitors
- (2020) Aviram Kogot-Levin et al. Cell Reports
- The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies
- (2020) Maria Tziastoudi et al. Clinical Kidney Journal
- Canagliflozin ameliorates renal oxidative stress and inflammation by stimulating AMPK–Akt–eNOS pathway in the isoprenaline-induced oxidative stress model
- (2020) Raquibul Hasan et al. Scientific Reports
- Purinergic signalling in the kidney: In physiology and disease
- (2020) Marie-Louise T. Monaghan et al. BIOCHEMICAL PHARMACOLOGY
- Oxidative Storm Induced by Tryptophan Metabolites: Missing Link between Atherosclerosis and Chronic Kidney Disease
- (2020) Iwona Kwiatkowska et al. Oxidative Medicine and Cellular Longevity
- Angiotensin-(3–4) normalizes blood pressure, decreases Na+ and energy intake, but preserves urinary Na+ excretion in overweight hypertensive rats
- (2020) Rafael Luzes et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Analysis from the EMPA-REG OUTCOME® trial indicate empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics
- (2019) Gert J. Mayer et al. KIDNEY INTERNATIONAL
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metabolomics analysis elucidates unique influences on purine / pyrimidine metabolism by xanthine oxidoreductase inhibitors in a rat model of renal ischemia-reperfusion injury
- (2019) Takashi Tani et al. MOLECULAR MEDICINE
- NAD+ homeostasis in renal health and disease
- (2019) Kenneth M. Ralto et al. Nature Reviews Nephrology
- Testosterone Increases the Expression and Phosphorylation of AMP kinase α in Men with Hypogonadism and Type 2 Diabetes
- (2019) Husam Ghanim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease
- (2019) Sho Hasegawa et al. KIDNEY INTERNATIONAL
- SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
- (2018) Dustin M. Lee et al. Cardiovascular Diabetology
- Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
- (2018) Allison Agus et al. Cell Host & Microbe
- Quantitative Analysis of NAD Synthesis-Breakdown Fluxes
- (2018) Ling Liu et al. Cell Metabolism
- Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease
- (2018) Xiaohong Liu et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
- (2018) Hiroyuki Umino et al. Scientific Reports
- Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits
- (2017) Jens Oellgaard et al. KIDNEY INTERNATIONAL
- Adenosine signaling in diabetes mellitus and associated cardiovascular and renal complications
- (2017) Maria Peleli et al. MOLECULAR ASPECTS OF MEDICINE
- Daily Intake of Grape Powder Prevents the Progression of Kidney Disease in Obese Type 2 Diabetic ZSF1 Rats
- (2017) Salwa Almomen et al. Nutrients
- Increased plasma serotonin metabolite 5-hydroxyindole acetic acid concentrations are associated with impaired systolic and late diastolic forward flows during cardiac cycle and elevated resistive index at popliteal artery and renal insufficiency in type 2 diabetic patients with microalbuminuria
- (2016) Jun Saito et al. ENDOCRINE JOURNAL
- Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
- (2016) Maryam Afkarian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease
- (2016) Tomonori Kimura et al. Scientific Reports
- Adenosine A2a receptor stimulation prevents proteinuria in diabetic rats by promoting an anti-inflammatory phenotype without affecting oxidative stress
- (2015) P. Persson et al. Acta Physiologica
- Hypoxia Inhibits Cavin-1 and Cavin-2 Expression and Down-Regulates Caveolae in Adipocytes
- (2015) Claire Regazzetti et al. ENDOCRINOLOGY
- Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes
- (2015) Gregory F. Oxenkrug MOLECULAR NEUROBIOLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mind the gap: connexins and cell–cell communication in the diabetic kidney
- (2014) Claire E. Hills et al. DIABETOLOGIA
- Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
- (2013) Michael G. Shlipak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits
- (2013) Gordon F. Rushworth et al. PHARMACOLOGY & THERAPEUTICS
- Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction
- (2012) JingXian Fang et al. BIOSCIENCE REPORTS
- Plasma Prolylcarboxypeptidase (Angiotensinase C) Is Increased in Obesity and Diabetes Mellitus and Related to Cardiovascular Dysfunction
- (2012) S. Xu et al. CLINICAL CHEMISTRY
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
- (2012) Lesley A. Inker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin-(3–4) counteracts the Angiotensin II inhibitory action on renal Ca2+-ATPase through a cAMP/PKA pathway
- (2012) Flavia Axelband et al. REGULATORY PEPTIDES
- Role of oxidative stress in diabetes-mediated vascular dysfunction: Unifying hypothesis of diabetes revisited
- (2012) Stephen W. Schaffer et al. VASCULAR PHARMACOLOGY
- Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway
- (2010) A. A. Khutornenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of renal arteriolar tone by adenosine: novel role for type 2 receptors
- (2009) Tracy D. Bell et al. KIDNEY INTERNATIONAL
- Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate
- (2008) Xun Li et al. CANCER SCIENCE
- ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy
- (2008) H.-H. Parving et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now